Purple Biotech
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -64 | -53 | -58 | |
EBITDA | 520 | 7 | -23,566 | -1,242 |
EBIT | 450 | -58 | -23,619 | -1,300 |
Net Income | 441 | -86 | -23,545 | -1,303 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,506 | -3,121 | -1,070 | -1,065 |
Cash | 5,236 | 5,567 | 8,717 | 9,592 |
Basic Shares | 10,860 | 9,306 | 11,908 | 4,555 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $195 | $-910 |
Gross Profit | -204 | -186 | ||
EBITDA | -26,250 | -7,052 | -19,724 | -21,492 |
EBIT | -26,453 | -7,238 | -19,921 | -21,693 |
Net Income | -26,386 | -7,240 | -19,880 | -21,668 |
Net Change In Cash | 0 | 0 | 195 | -910 |
Free Cash Flow | -5,539 | -14,367 | -19,928 | -16,963 |
Cash | 8,716 | 7,401 | 14,489 | 15,030 |
Basic Shares | 4,800 | 1,639 | 1,106 | 904 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $1.07 |
2026-03-31 | -$2.32 |
2025-12-31 | -$6.16 |
2025-09-30 | $2.90 |